"Amyloidogenic Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins that form the core of amyloid fibrils. For example, the core of amyloid A is formed from amyloid A protein, also known as serum amyloid A protein or SAA protein.
| Descriptor ID |
D058227
|
| MeSH Number(s) |
D12.776.049.407
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Amyloidogenic Proteins".
Below are MeSH descriptors whose meaning is more specific than "Amyloidogenic Proteins".
This graph shows the total number of publications written about "Amyloidogenic Proteins" by people in this website by year, and whether "Amyloidogenic Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amyloidogenic Proteins" by people in Profiles.
-
Systemic exposure to bacterial amyloid curli alters the gut mucosal immune response and the microbiome, exacerbating Salmonella-induced arthritis. Gut Microbes. 2023 Jan-Dec; 15(1):2221813.
-
Development of a quantitative semi-mechanistic model of Alzheimer's disease based on the amyloid/tau/neurodegeneration framework (the Q-ATN model). Alzheimers Dement. 2023 06; 19(6):2287-2297.
-
Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease. Alzheimers Res Ther. 2022 11 29; 14(1):178.
-
Shared mechanisms: osteoporosis and Alzheimer's disease? Aging (Albany NY). 2019 02 19; 11(5):1317-1318.
-
Use of magnetization transfer contrast MRI to detect early molecular pathology in Alzheimer's disease. Magn Reson Med. 2014 Jan; 71(1):333-8.
-
Binding with nucleic acids or glycosaminoglycans converts soluble protein oligomers to amyloid. J Biol Chem. 2012 Jan 02; 287(1):736-747.
-
Role of oligomers in the amyloidogenesis of primary cutaneous amyloidosis. J Am Acad Dermatol. 2011 Nov; 65(5):1023-31.
-
Report of the task force on designing clinical trials in early (predementia) AD. Neurology. 2011 Jan 18; 76(3):280-6.